408 A phase II study of erlotinib in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (PHL-002e/NCIC CTG IND.157)
2004 ◽
Vol 2
(8)
◽
pp. 122
◽
Keyword(s):
Phase Ii
◽